These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23953841)

  • 1. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.
    Chen J; Pompano RR; Santiago FW; Maillat L; Sciammas R; Sun T; Han H; Topham DJ; Chong AS; Collier JH
    Biomaterials; 2013 Nov; 34(34):8776-85. PubMed ID: 23953841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes.
    Wu Y; Kelly SH; Sanchez-Perez L; Sampson JH; Collier JH
    Biomater Sci; 2020 Jun; 8(12):3522-3535. PubMed ID: 32452474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.
    de Oliveira GA; Clavijo P; Nussenzweig RS; Nardin EH
    Vaccine; 1994 Aug; 12(11):1012-7. PubMed ID: 7526570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
    Mora-Solano C; Wen Y; Han H; Chen J; Chong AS; Miller ML; Pompano RR; Collier JH
    Biomaterials; 2017 Dec; 149():1-11. PubMed ID: 28982051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML; Bernhard H; Shiota FM; Hand SL; Gralow JR; Huseby ES; Gillis S; Cheever MA
    Blood; 1996 Jul; 88(1):202-10. PubMed ID: 8704175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8
    Si Y; Wen Y; Kelly SH; Chong AS; Collier JH
    J Control Release; 2018 Jul; 282():120-130. PubMed ID: 29673645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen.
    Onishi M; Ozasa K; Kobiyama K; Ohata K; Kitano M; Taniguchi K; Homma T; Kobayashi M; Sato A; Katakai Y; Yasutomi Y; Wijaya E; Igarashi Y; Nakatsu N; Ise W; Inoue T; Yamada H; Vandenbon A; Standley DM; Kurosaki T; Coban C; Aoshi T; Kuroda E; Ishii KJ
    J Immunol; 2015 Mar; 194(6):2673-82. PubMed ID: 25681338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.
    Rudra JS; Mishra S; Chong AS; Mitchell RA; Nardin EH; Nussenzweig V; Collier JH
    Biomaterials; 2012 Sep; 33(27):6476-84. PubMed ID: 22695068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).
    Schmidt ST; Pedersen GK; Neustrup MA; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Front Immunol; 2018; 9():898. PubMed ID: 29760705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses.
    Rudra JS; Banasik BN; Milligan GN
    Vaccine; 2018 Jan; 36(4):438-441. PubMed ID: 29248267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines.
    Skwarczynski M; Zhao G; Boer JC; Ozberk V; Azuar A; Cruz JG; Giddam AK; Khalil ZG; Pandey M; Shibu MA; Hussein WM; Nevagi RJ; Batzloff MR; Wells JW; Capon RJ; Plebanski M; Good MF; Toth I
    Sci Adv; 2020 Jan; 6(5):eaax2285. PubMed ID: 32064333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses.
    Chesson CB; Huelsmann EJ; Lacek AT; Kohlhapp FJ; Webb MF; Nabatiyan A; Zloza A; Rudra JS
    Vaccine; 2014 Feb; 32(10):1174-80. PubMed ID: 24308959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.
    Dong S; Xu T; Wang P; Zhao P; Chen M
    Acta Pharmacol Sin; 2017 Jun; 38(6):914-923. PubMed ID: 28414197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. This paper is the winner of an SFB Award in the Hospital Intern, Residency category: Peptide biomaterials raising adaptive immune responses in wound healing contexts.
    Vigneswaran Y; Han H; De Loera R; Wen Y; Zhang X; Sun T; Mora-Solano C; Collier JH
    J Biomed Mater Res A; 2016 Aug; 104(8):1853-62. PubMed ID: 27129604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
    Pardi N; Hogan MJ; Naradikian MS; Parkhouse K; Cain DW; Jones L; Moody MA; Verkerke HP; Myles A; Willis E; LaBranche CC; Montefiori DC; Lobby JL; Saunders KO; Liao HX; Korber BT; Sutherland LL; Scearce RM; Hraber PT; Tombácz I; Muramatsu H; Ni H; Balikov DA; Li C; Mui BL; Tam YK; Krammer F; Karikó K; Polacino P; Eisenlohr LC; Madden TD; Hope MJ; Lewis MG; Lee KK; Hu SL; Hensley SE; Cancro MP; Haynes BF; Weissman D
    J Exp Med; 2018 Jun; 215(6):1571-1588. PubMed ID: 29739835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
    Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
    Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
    Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.